Aldana Rosso

1.8k total citations · 2 hit papers
52 papers, 1.1k citations indexed

About

Aldana Rosso is a scholar working on Atomic and Molecular Physics, and Optics, Pulmonary and Respiratory Medicine and Artificial Intelligence. According to data from OpenAlex, Aldana Rosso has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Atomic and Molecular Physics, and Optics, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Artificial Intelligence. Recurrent topics in Aldana Rosso's work include Advanced Chemical Physics Studies (12 papers), AI in cancer detection (9 papers) and Digital Radiography and Breast Imaging (7 papers). Aldana Rosso is often cited by papers focused on Advanced Chemical Physics Studies (12 papers), AI in cancer detection (9 papers) and Digital Radiography and Breast Imaging (7 papers). Aldana Rosso collaborates with scholars based in Sweden, Denmark and Germany. Aldana Rosso's co-authors include Kristina Lång, Ingvar Andersson, Sophia Zackrisson, Pontus Timberg, Hanna Sartor, Anders Tingberg, Anna-Maria Larsson, Solveig Hofvind, Stefan Larsson and Charlotte Högberg and has published in prestigious journals such as The Lancet, Journal of the American Chemical Society and The Journal of Chemical Physics.

In The Last Decade

Aldana Rosso

50 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study

2023 237 citations Kristina Lång, Anna-Maria Larsson et al. The Lancet Oncology profile →
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study

2025 35 citations Hanna Sartor, David Schmidt et al. The Lancet Digital Health profile →

Peers

Aldana Rosso

PRM

RNMI

ONCOL

AMPO

Michael Ingrisch Germany

Carsten Brink Denmark

Kujtim Latifi United States

Anna M. Brown United States

M Vićić United States

C. Y. Hu China

Daniel Paech Germany

Colin M. Carpenter United States

David Thwaites Australia

Hiroyuki Okamoto Japan

Michael Ingrisch Germany

Aldana Rosso

218 ×0.5

456 ×1.0

PRM

1.6k ×3.7

RNMI

192 ×0.9

ONCOL

103 ×0.7

AMPO

Citations per year, relative to Aldana Rosso Aldana Rosso (= 1×) peers Michael Ingrisch

Countries citing papers authored by Aldana Rosso

Since Specialization

Citations

This map shows the geographic impact of Aldana Rosso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aldana Rosso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aldana Rosso more than expected).

Fields of papers citing papers by Aldana Rosso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aldana Rosso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aldana Rosso. The network helps show where Aldana Rosso may publish in the future.

Co-authorship network of co-authors of Aldana Rosso

This figure shows the co-authorship network connecting the top 25 collaborators of Aldana Rosso. A scholar is included among the top collaborators of Aldana Rosso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aldana Rosso. Aldana Rosso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sartor, Hanna, et al.. (2026). Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy trial. The Lancet. 407(10527). 505–514. 1 indexed citations

Sartor, Hanna, David Schmidt, Anna-Maria Larsson, et al.. (2025). Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study. The Lancet Digital Health. 7(3). e175–e183. 35 indexed citations breakdown →

Ekström, Henrik, et al.. (2024). Association of polypharmacy, fall-risk-increasing drugs, and cardiovascular drugs with loneliness and social isolation among older adults. SHILAP Revista de lepidopterología. 1(4). 100089–100089.

Rosso, Aldana, et al.. (2024). Chronic kidney disease and its association with cerebral small vessel disease in the general older hypertensive population. BMC Nephrology. 25(1). 93–93. 3 indexed citations

Paller, Amy S., Weily Soong, Mark Boguniewicz, et al.. (2024). 548 - Tralokinumab improves signs and symptoms of moderate-to-severe atopic dermatitis in patients aged 12 years and older with and without atopic comorbidities. British Journal of Dermatology. 190(Supplement_2). ii46–ii47. 1 indexed citations

Rosso, Aldana, et al.. (2024). Elevated pulse pressure preceded incident chronic kidney disease in the general older population in Sweden. Scientific Reports. 14(1). 15414–15414. 1 indexed citations

Paller, Amy S., Weily Soong, Mark Boguniewicz, et al.. (2024). Tralokinumab Improves Signs and Symptoms of Moderate-to-Severe Atopic Dermatitis in Patients Aged 12 years and Older With and Without Atopic Comorbidities. SKIN The Journal of Cutaneous Medicine. 8(1). s322–s322. 1 indexed citations

Rosso, Aldana, et al.. (2023). Cognitive decline and risk of dementia in older adults after diagnosis of chronic obstructive pulmonary disease. npj Primary Care Respiratory Medicine. 33(1). 20–20. 2 indexed citations

Johnson, Kristin, et al.. (2023). False-positive recalls in the prospective Malmö Breast Tomosynthesis Screening Trial. European Radiology. 33(11). 8089–8099. 6 indexed citations

10.

Ekström, Henrik, et al.. (2023). Association of polypharmacy with occurrence of loneliness and social isolation among older adults. Archives of Gerontology and Geriatrics. 116. 105158–105158. 9 indexed citations

11.

Lång, Kristina, Anna-Maria Larsson, Stefan Larsson, et al.. (2023). Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study. The Lancet Oncology. 24(8). 936–944. 237 indexed citations breakdown →

12.

Rosso, Aldana, et al.. (2022). Annual decline rate in FEV1s in community-dwelling older adults diagnosed with mild to moderate COPD. npj Primary Care Respiratory Medicine. 32(1). 30–30. 7 indexed citations

13.

Penninga, Elisabeth I, Doris Hovgaard, Aldana Rosso, et al.. (2020). EMA Review of Daratumumab (Darzalex) for the Treatment of Adult Patients Newly Diagnosed with Multiple Myeloma. The Oncologist. 25(12). 1067–1074. 4 indexed citations

14.

Johnson, Kristin, Sophia Zackrisson, Aldana Rosso, et al.. (2019). Tumor Characteristics and Molecular Subtypes in Breast Cancer Screening with Digital Breast Tomosynthesis: The Malmö Breast Tomosynthesis Screening Trial. Radiology. 293(2). 273–281. 22 indexed citations

15.

Zackrisson, Sophia, Kristina Lång, Aldana Rosso, et al.. (2018). One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study. The Lancet Oncology. 19(11). 1493–1503. 118 indexed citations

16.

Granstam, Elisabet, et al.. (2017). Treatment for neovascular age‐related macular degeneration in Sweden: outcomes at seven years in the Swedish Macula Register. Acta Ophthalmologica. 95(8). 787–795. 27 indexed citations

17.

Solá, Montserrat, et al.. (2017). Evaluating depression in elderly patients with cancer. Annals of Oncology. 28. vi82–vi82. 1 indexed citations

18.

Lång, Kristina, Kristina Stenström, Aldana Rosso, et al.. (2016). ¹⁴C BOMB-PULSE DATING AND STABLE ISOTOPE ANALYSIS FOR GROWTH RATE AND DIETARY INFORMATION IN BREAST CANCER?. Radiation Protection Dosimetry. 169(1-4). 158–164. 2 indexed citations

19.

Sartor, Hanna, Kristina Lång, Aldana Rosso, et al.. (2016). Measuring mammographic density: comparing a fully automated volumetric assessment versus European radiologists’ qualitative classification. European Radiology. 26(12). 4354–4360. 44 indexed citations

20.

Lång, Kristina, Ingvar Andersson, Aldana Rosso, et al.. (2015). Performance of one-view breast tomosynthesis as a stand-alone breast cancer screening modality: results from the Malmö Breast Tomosynthesis Screening Trial, a population-based study. European Radiology. 26(1). 184–190. 210 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact